Director Gary Sender receives 21,872 stock options at Harmony Biosciences (HRMY)

Rhea-AI Filing Summary

Harmony Biosciences Holdings, Inc. director Gary Sender reported a grant of stock options covering 21,872 shares of common stock. The options have an exercise price of $30.76 per share and expire on May 14, 2036. They vest in full on the earlier of May 14, 2027 or the next annual meeting following the grant date, subject to continued service. This is a compensation-related award rather than an open-market trade.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sender Gary

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	21,872	$0.00	--

Holdings After Transaction: Stock Option — 21,872 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock options granted: 21,872 options Exercise price: $30.76 per share Expiration date: May 14, 2036 +1 more

4 metrics

Stock options granted 21,872 options Grant to director Gary Sender

Exercise price $30.76 per share Strike price of stock option grant

Expiration date May 14, 2036 Option term end

Shares underlying options 21,872 shares Common stock underlying granted options

Key Terms

Stock Option, exercise price, expiration date, Form 4, +1 more

5 terms

Stock Option financial

"security_title: "Stock Option" with underlying common stock"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"conversion_or_exercise_price of 30.7600 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date set to 2036-05-14T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Form 4 regulatory

"INSIDER FILING DATA (Form 4) for Harmony Biosciences"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

vest in full financial

"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sender Gary

(Last) (First) (Middle)

C/O HARMONY BIOSCIENCES HOLDINGS, INC.

630 W GERMANTOWN PIKE, SUITE 215

(Street)

PLYMOUTH MEETING PENNSYLVANIA 19462

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Harmony Biosciences Holdings, Inc. [ HRMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$30.76	05/14/2026		A		21,872		(1)	05/14/2036	Common Stock	21,872	$0	21,872	D

Explanation of Responses:

1. The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

	/s/ Christian Ulrich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Harmony Biosciences (HRMY) director Gary Sender report?

Gary Sender reported receiving a stock option grant for 21,872 shares of Harmony Biosciences common stock. The award is a compensation-related grant, not an open-market trade, and gives him the right to buy shares at a fixed exercise price if it vests.

What is the exercise price of Gary Sender’s new Harmony Biosciences (HRMY) stock options?

The stock options granted to Gary Sender have an exercise price of $30.76 per share. This means he can purchase Harmony Biosciences common stock at $30.76 if the options vest and he chooses to exercise them before they expire.

When do Gary Sender’s Harmony Biosciences (HRMY) stock options vest?

Gary Sender’s stock options vest in full on the earlier of May 14, 2027, or the date of the next annual meeting after the grant. Vesting is conditional on his continued service with Harmony Biosciences through the applicable vesting date.

When do Gary Sender’s Harmony Biosciences (HRMY) stock options expire?

The stock options granted to Gary Sender expire on May 14, 2036. If he does not exercise them by that expiration date, the right to purchase Harmony Biosciences shares at the $30.76 exercise price will lapse and become worthless.

Is Gary Sender’s Harmony Biosciences (HRMY) Form 4 transaction a stock purchase or sale?

The Form 4 transaction reflects a grant of stock options, not a purchase or sale of shares in the open market. It is a compensation-related award giving him potential future rights to acquire Harmony Biosciences common stock.